A simulation model of building intervention impacts on indoor environmental quality, pediatric asthma, and costs Maria Patricia Fabian, ScD, Gary Adamkiewicz,

Slides:

Advertisements

Similar presentations

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Advertisements

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

Home Environmental Interventions for the Prevention or Control of Allergic and Respiratory Diseases: What Really Works Pierre Le Cann, PhD, Hélène Paulus,

Allergen immunotherapy: A practice parameter third update

Risk of an asthma exacerbation after bariatric surgery in adults

Clarification concerning amoxicillin skin testing

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life? Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Applying epidemiologic concepts of primary, secondary, and tertiary prevention to the elimination of racial disparities in asthma Christine L.M. Joseph,

Is 9 more than 2 also in allergic airway inflammation?

Desensitization to Chemotherapeutic Agents

The role of air pollution in asthma and other pediatric morbidities

An Infant with Atopic Dermatitis and Itching After Ingestion of Milk

NAEPP Expert Panel Report

Changing trends and challenges in the management of asthma in Asia

Advancing asthma care: The glass is only half full!

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Allergy testing in predicting outcome of open food challenge to peanut

The National Biome Initiative: An allergy perspective

Vitamin D levels and food and environmental allergies in the United States: Results from the National Health and Nutrition Examination Survey

Nonadherence to Asthma Treatment: Getting Unstuck

Peter M. Wolfgram, MD, David B. Allen, MD

Etiology of asthma exacerbations

United Nations Climate Change Conferences: COP21 a lost opportunity for asthma and allergies and preparing for COP22 Isabella Annesi-Maesano, MD, PhD,

Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA

Reply Journal of Allergy and Clinical Immunology

Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S

Phillip Lieberman, MD, Michael Tankersley, MD

Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation Leif Bjermer, MD Journal of Allergy.

What are the best outcome measurements for atopic eczema

Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management Scott H. Sicherer, MD, Hugh A. Sampson, MD Journal.

Biosimilars and drug development in allergic and immunologic diseases

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS

What is an “eosinophilic phenotype” of asthma?

Lyndsey A. Darrow, PhD, Jeremy Hess, MD, Christine A

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

Cockroach allergens: Coping with challenging complexity

Autophagy: Nobel Prize 2016 and allergy and asthma research

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment

Advances in the approach to the patient with food allergy

A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children Felicia A. Rabito, PhD, MPH, John C. Carlson,

Felicia A. Rabito, PhD, Shahed Iqbal, PhD, Michael P

Mary F. Linehan, PhD, Timothy L. Frank, MD, Michelle L

New pathways for itching in patients with atopic dermatitis?

Airborne mouse allergen in the homes of inner-city children with asthma Elizabeth C. Matsui, MD, MHS, Elinor Simons, MD, Cynthia Rand, PhD, Arlene Butz,

One step forward, 2 steps back: The enigma of preschool wheeze

News Beyond Our Pages Journal of Allergy and Clinical Immunology

Risk of oral food challenges

The National Institutes of Allergy and Infectious Diseases networks on asthma in inner- city children: An approach to improved care William W. Busse,

Martin Brasholt, MD, Florent Baty, PhD, Hans Bisgaard, MD, DMSci

The role of indoor allergens in chronic allergic disease

Cost of near-roadway and regional air pollution–attributable childhood asthma in Los Angeles County Sylvia Brandt, PhD, Laura Perez, PhD, Nino Künzli,

Thunderstorm-related asthma attacks

Measles and immunomodulation

Asthma progression: Can we and should we measure it?

Päivi M. Salo, PhD, Samuel J. Arbes, DDS, MPH, PhD, Patrick W

Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.

Macrolide antibiotics and asthma treatment

Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.

Asthma: The past, future, environment, and costs

Environmental factors and eosinophilic esophagitis

News & Notes Journal of Allergy and Clinical Immunology

The GILL study: Glycerin-induced local reactions in immunotherapy

Systemic responses after bronchial aspirin challenge in sensitive patients with asthma Joanna S. Makowska, MD, PhD, Janina Grzegorczyk, PhD, Barbara Bienkiewicz,

Advances in pediatric asthma in 2007

Safety and efficacy of repeated monthly carboplatin desensitization

Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,

Natural history of cow’s milk allergy

Primary prevention of asthma and allergy

Modeling asthma exacerbations through lung function in children

Presentation transcript:

A simulation model of building intervention impacts on indoor environmental quality, pediatric asthma, and costs Maria Patricia Fabian, ScD, Gary Adamkiewicz, PhD, Natasha Kay Stout, PhD, Megan Sandel, MD, Jonathan Ian Levy, ScD Journal of Allergy and Clinical Immunology Volume 133, Issue 1, Pages 77-84 (January 2014) DOI: 10.1016/j.jaci.2013.06.003 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Schematic of the pediatric asthma discrete event simulation model. Journal of Allergy and Clinical Immunology 2014 133, 77-84DOI: (10.1016/j.jaci.2013.06.003) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Percentage change in pollutant concentrations for each intervention scenario compared with the baseline scenario: A, NO2; B, PM2.5. HEPA, High-efficiency particulate air. Journal of Allergy and Clinical Immunology 2014 133, 77-84DOI: (10.1016/j.jaci.2013.06.003) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Percentage change in health outcomes for each intervention compared with the baseline scenario. A, Asthma symptom days include days with any symptom, including wheeze, cough, and nighttime awakenings. B, Serious events include asthma hospitalizations, ED visits, and clinic visits. Asthma outcomes reflect changes in exposure to NO2, PM2.5, cockroach allergen, and damp homes. HEPA, High-efficiency particulate air. Journal of Allergy and Clinical Immunology 2014 133, 77-84DOI: (10.1016/j.jaci.2013.06.003) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Changes in costs of health care use for each intervention compared with baseline averaged over all asthmatic patients. HEPA, High-efficiency particulate air. Journal of Allergy and Clinical Immunology 2014 133, 77-84DOI: (10.1016/j.jaci.2013.06.003) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions